Table of Contents
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2023-2024)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Amyotrophic Lateral Sclerosis Market Snapshot (2023-2029)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Increasing prevalence of ALS globally
- Advancements in biotechnology
- Growing investments in ALS research and drug development
- Restraints
- Lack of clear understanding of ALS pathogenesis
- High costs of drug development and clinical trials
- Limited number of approved therapies
- Opportunities
- Development of disease-modifying therapies
- Adoption of telemedicine and remote monitoring for ALS patient management
- Key Market Trends
- Increasing focus on gene-editing and gene-based therapies
- Adoption of advanced rehabilitation and respiratory support technologies
- Drivers
- Unmet Market Needs
- Industry Speaks
- Regulatory Analysis
- Market Dynamics
- Global Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Treatment, USD Million
- Introduction
- Medication
- Riluzole
- Edaravone
- Others
Global Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Type, USD Million
- Introduction
- Sporadic ALS
- Familial ALS
- Global Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Distribution Channel, USD Million
- Introduction
- Hospitals Pharmacies
- Retail Pharmacies
- Others
- Global Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Region, USD Million
- Introduction
- North America Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Country, USD Million
- US
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market S)
- Canada
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- US
- Europe Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Country, USD Million
- UK
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
-
- Germany
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- France
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Italy
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Spain
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Germany
- Asia Pacific (APAC) Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Country, USD Million
- China
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Japan
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- India
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecas Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- China
- Latin America (LATAM) Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Middle East & Africa (MEA) Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Treatment (USD Million)
- Market Size & Forecast, By Type (USD Million
- Market Size & Forecast, By Distribution Channel (USD Million)
-
- Competitive Landscape
- Key Players andise Player Mapping
- Market Share Analysis (2023)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
-
- Amylyx Pharmaceuticals, Inc.
- Biogen
- BrainStorm Cell Limited
- Ionis Pharmaceuticals, Inc.
- Mitsubishi Tanabe Pharma Corporation
- Sanofi
- Otsuka Pharmaceutical Co., Ltd.
- Hoffmann-La Roche Ltd
- AB Science
- Sun Pharmaceutical Industries Ltd.
- Orion Corporation
- Other Prominent Players
Note: *Indicative list
**For listed companies</
- UK